What may seem like a technical exercise in global health bureaucracy- the World Health Organization’s update to its Essential ...

WHO has updated its Essential Medicines Lists, adding new cancer, diabetes, obesity, and cystic fibrosis treatments, aiming to improve global access, reduce costs, and provide life-saving care for ...

Nupur Lalvani says the inclusion of rapid-acting insulin analogues and GLP-1 receptor agonists in the WHO list of essential medicines will reduce out-of-pocket costs for diabetes care.

WHO has added semaglutide-used in Ozempic-to its 2025 Essential Medicines List, aiming to expand global access to key ...

The World Health Organisation’s (WHO) has announced the inclusion of rapid-acting insulin analogues and GLP-1 receptor ...

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

Artificial intelligence has disrupted, enhanced and changed our lives forever. And it happened quickly. At its opposite, almost in response to technological progress, a return to analogue is gathering ...

Adherence to an app-based insulin dosing guide was associated with improved self-measured blood glucose among patients with type 2 diabetes.

DETROIT – Despite advances in insulin therapy and automated delivery systems, people with Type 1 diabetes (T1D) still face a daily struggle: manually dosing insulin before meals. Current insulin ...

An individual develops insulin resistance when cells fail to properly respond to insulin, which serves as the hormone for sugar energy utilisation. The condition results in elevated blood sugar levels ...

A study published in Pregnancy suggests that inhaled technosphere insulin may be a safe alternative to rapid-acting insulin analogs for diabetes management during pregnancy. Cases demonstrated ...

Advanced Materials Laboratory, CSIR-Central Leather Research Institute, Sardar Patel Road, Adyar, Chennai 600 020, India ...